Literature DB >> 21196420

Exercise program adherence using a 5-kilometer (5K) event as an achievable goal in people with schizophrenia.

Kimberly R Warren1, M Patricia Ball, Stephanie Feldman, Fang Liu, Robert P McMahon, Deanna L Kelly.   

Abstract

People with schizophrenia have a higher prevalence of obesity than the general population. Many people with this illness struggle with weight gain, due, in part, to medications and other factors that act as obstacles to exercise and healthy eating. Several studies have shown the benefits of behavioral weight loss programs targeting eating and/or exercise in people with schizophrenia. Fewer studies have used competitive events as a goal for an exercise program. The current study tested the feasibility of preparing, using an exercise program, for a 5-kilometer (5K) event in people with schizophrenia. The exercise program was a 10-week training program consisting of three supervised walking/jogging sessions per week and a weekly educational meeting on healthy behaviors. Almost 65% (11/17) of the subjects participated in all of the training sessions, and 82% (14/17) participated in the 5K event. Participants did not gain a significant amount of weight during the exercise program (median weight change = 0.7 kg; 25th percentile 0.5, 75th percentile 3.9, p = .10). This study suggests that using an achievable goal, such as a 5K event, promotes adherence to an exercise program and is feasible in a population of people with chronic schizophrenia.

Entities:  

Mesh:

Year:  2010        PMID: 21196420      PMCID: PMC3742087          DOI: 10.1177/1099800410393272

Source DB:  PubMed          Journal:  Biol Res Nurs        ISSN: 1099-8004            Impact factor:   2.522


  48 in total

Review 1.  The role of lifestyle interventions and weight management in schizophrenia.

Authors:  Chris Bushe; Peter Haddad; Robert Peveler; John Pendlebury
Journal:  J Psychopharmacol       Date:  2005-11       Impact factor: 4.153

2.  A program for treating olanzapine-related weight gain.

Authors:  M P Ball; V B Coons; R W Buchanan
Journal:  Psychiatr Serv       Date:  2001-07       Impact factor: 3.084

3.  Introduction: cardiovascular disease and metabolic risk factors in patients with mental illness.

Authors:  John W Newcomer
Journal:  CNS Spectr       Date:  2008-06       Impact factor: 3.790

4.  Effect of antipsychotic withdrawal on extrapyramidal symptoms: statistical methods for analyzing single-sample repeated-measures data.

Authors:  S Arndt; C S Davis; D D Miller; N C Andreasen
Journal:  Neuropsychopharmacology       Date:  1993-01       Impact factor: 7.853

5.  Effects of behavioral therapy on weight loss in overweight and obese patients with schizophrenia or schizoaffective disorder.

Authors:  Jaspreet S Brar; Rohan Ganguli; Gahan Pandina; Ibrahim Turkoz; Sally Berry; Ramy Mahmoud
Journal:  J Clin Psychiatry       Date:  2005-02       Impact factor: 4.384

6.  Hippocampal plasticity in response to exercise in schizophrenia.

Authors:  Frank-Gerald Pajonk; Thomas Wobrock; Oliver Gruber; Harald Scherk; Dorothea Berner; Inge Kaizl; Astrid Kierer; Stephanie Müller; Martin Oest; Tim Meyer; Martin Backens; Thomas Schneider-Axmann; Allen E Thornton; William G Honer; Peter Falkai
Journal:  Arch Gen Psychiatry       Date:  2010-02

7.  Evaluation of a behavioural weight management programme for patients with severe mental illness: 3 year results.

Authors:  John Pendlebury; Peter Haddad; Serdar Dursun
Journal:  Hum Psychopharmacol       Date:  2005-08       Impact factor: 1.672

8.  Do antipsychotic medications reduce or increase mortality in schizophrenia? A critical appraisal of the FIN-11 study.

Authors:  Marc De Hert; Christoph U Correll; Dan Cohen
Journal:  Schizophr Res       Date:  2010-01-12       Impact factor: 4.939

9.  Tolerability of outpatient antipsychotic treatment: 36-month results from the European Schizophrenia Outpatient Health Outcomes (SOHO) study.

Authors:  Diego Novick; Josep Maria Haro; Elena Perrin; David Suarez; João Marques Texeira
Journal:  Eur Neuropsychopharmacol       Date:  2009-06-04       Impact factor: 4.600

10.  A pilot study of a weight management program with food provision in schizophrenia.

Authors:  Michel Jean-Baptiste; Cenk Tek; Ellen Liskov; Umesh Rao Chakunta; Sarah Nicholls; Akm Q Hassan; Kelly D Brownell; Bruce E Wexler
Journal:  Schizophr Res       Date:  2007-07-12       Impact factor: 4.939

View more
  6 in total

Review 1.  The effects of physical exercise in schizophrenia and affective disorders.

Authors:  Berend Malchow; Daniela Reich-Erkelenz; Viola Oertel-Knöchel; Katriona Keller; Alkomiet Hasan; Andrea Schmitt; Thomas W Scheewe; Wiepke Cahn; René S Kahn; Peter Falkai
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2013-07-20       Impact factor: 5.270

Review 2.  Exercise Improves Clinical Symptoms, Quality of Life, Global Functioning, and Depression in Schizophrenia: A Systematic Review and Meta-analysis.

Authors:  Meenakshi Dauwan; Marieke J H Begemann; Sophie M Heringa; Iris E Sommer
Journal:  Schizophr Bull       Date:  2015-11-07       Impact factor: 9.306

3.  Nonpharmacological Interventions for the Treatment of Cardiometabolic Risk Factors in People With Schizophrenia-A Systematic Review.

Authors:  Ewa Tumiel; Adam Wichniak; Marek Jarema; Michał Lew-Starowicz
Journal:  Front Psychiatry       Date:  2019-08-16       Impact factor: 4.157

4.  A brief intervention to improve exercising in patients with schizophrenia: a controlled pilot study with mental contrasting and implementation intentions (MCII).

Authors:  Pascal Sailer; Frank Wieber; Karl Pröpster; Steffen Stoewer; Daniel Nischk; Franz Volk; Michael Odenwald
Journal:  BMC Psychiatry       Date:  2015-09-03       Impact factor: 3.630

5.  The health benefits and challenges of exercise training in persons living with schizophrenia: a pilot study.

Authors:  Shannon S D Bredin; Darren E R Warburton; Donna J Lang
Journal:  Brain Sci       Date:  2013-05-24

6.  Animal Assisted Therapy (AAT) Program As a Useful Adjunct to Conventional Psychosocial Rehabilitation for Patients with Schizophrenia: Results of a Small-scale Randomized Controlled Trial.

Authors:  Paula Calvo; Joan R Fortuny; Sergio Guzmán; Cristina Macías; Jonathan Bowen; María L García; Olivia Orejas; Ferran Molins; Asta Tvarijonaviciute; José J Cerón; Antoni Bulbena; Jaume Fatjó
Journal:  Front Psychol       Date:  2016-05-06
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.